Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1021 of 5804
-
New microscope could speed up cervical cancer diagnosis in minutes
Diagnosis Not yet recruitingAll patients will be enrolled in Mozambique and Brazil. They will provide informed consent to use their cervical biopsy and/or LEEP specimens for imaging with DeepDOF prior to sending for standard of care processing and interpretation.
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
AI listens for dementia: new speech test could speed up diagnosis
Diagnosis Not yet recruitingThe goal of this observational study is to learn if an artificial intelligence (AI)-based speech analysis tool can identify which patients with memory problems need specialist evaluation at a memory clinic. The main questions it aims to answer are: Can the AI model accurately di…
Sponsor: Zealand University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New pill shows promise for rare blood disorder in Long-Term trial
Disease control Not yet recruitingNTQ5082 capsules are a small molecule CFB inhibitor. This study is a multicenter, open-label study evaluating the long-term efficacy and safety of NTQ5082 capsules in the treatment of patients with paroxysmal nocturnal hemoglobinuria
Phase: PHASE3 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Disease control
Last updated Jun 26, 2026 17:40 UTC
-
New prostate cancer radiation cuts sessions in half
Disease control Not yet recruitingThis is a single-arm, exploratory phase I clinical trial evaluating the safety and efficacy of ultra-hypofractionated carbon ion radiotherapy (CIRT) in 6 fractions compared to the conventional 12-fraction regimen in patients with low- and intermediate-risk localized prostate canc…
Phase: PHASE1 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Stem cell shot into ovaries aims to tame perimenopause symptoms
Disease control ENROLLING_BY_INVITATIONThis observational study examines the safety and effects of injecting Muse cells (a type of naturally occurring stem like cells found in adult tissues such as fat or bone marrow) directly into the ovaries of women aged 28 to 70 who are going through peri-menopause. Perimenopause…
Sponsor: Healing Hope International • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New heart implant aims to stop leaky valve symptoms
Disease control Not yet recruitingThe goal of this early feasibility clinical trial is to learn if the device MR-ace Implant and Delivery System works in patients with moderate or severe mitral valve regurgitation. It will also learn about the safety of the device MR-ace Implant and Delivery System. The main ques…
Phase: NA • Sponsor: Polares Medical SA • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Old sedative drug could tame ICU delirium better than antipsychotics
Symptom relief Not yet recruitingThe goal of this clinical trial is to test whether the medication phenobarbital is as effective for treating agitated delirium among adult patients admitted to the intensive care unit. Agitated delirium is a condition involving confusion and impulsiveness which is dangerous to bo…
Phase: PHASE3 • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New drug duo takes on Hard-to-Treat waldenstrom macroglobulinemia
Disease control Not yet recruitingThe purpose of this clinical trial it to test the safety and tolerability of the study drugs mosunetuzumab in combination with pirtobrutinib in patients with relapsed or refractory Waldenstrom's Macroglobulinemia.
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Nasal spray may curb Post-Surgery confusion in seniors
Symptom relief Not yet recruitingThis clinical trial is designed to observe the effect of dexmedetomidine nasal spray on the incidence of postoperative delirium in elderly patients undergoing thoracoscopic lung resection. Eligible elderly patients scheduled for thoracoscopic lung resection will be randomly divid…
Phase: PHASE4 • Sponsor: Sichuan Provincial People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Nerve-Cutting surgery could replace costly pumps for spasticity
Disease control Not yet recruitingThe investigators will investigate the selective dorsal rhizotomy in post traumatic brain and spinal cord injury induced spasticity to evaluate the efficacy of this procedure in reducing the tone of the spastic muscle groups. Selective dorsal rhizotomy is well established effect…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Balloon vs stent: new heart artery trial aims for better outcomes
Disease control Not yet recruitingTo compare the safety and efficacy of Biolimus drug-coated balloon (DCB) versus drug-eluting stent (DES) in the treatment of de novo coronary artery lesions.
Phase: NA • Sponsor: JW Medical Systems Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could a vaginal capsule wipe out persistent HPV?
Disease control Not yet recruitingThe goal of this clinical study is to learn if DARE-HPV can treat persistent high-risk human papillomavirus (hrHPV). The primary outcome will be if the genital infection clears following treatment in 30, 60 or 90 days. The study will look at two different doses of DARE-HPV and t…
Phase: PHASE2 • Sponsor: Daré Bioscience, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New pill aims to slow vision loss from dry macular degeneration
Disease control Not yet recruitingThe purpose of this clinical research study is to look at how safe STL303 is and whether it works when given to people with Geographic Atrophy (GA) secondary to Age-related Macular Degeneration (AMD). Geographic atrophy secondary to AMD is a condition where cells in the back part…
Phase: PHASE2 • Sponsor: Sitala Bio LTD • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New depression drug DT-101 enters Mid-Stage trial
Symptom relief Recruiting nowIn this study, researchers will learn more about a study drug called DT-101 in participants with Major Depressive Disorder (MDD), a form of depression. The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to p…
Phase: PHASE2 • Sponsor: Draig Therapeutics Ltd • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New ultrasound technique may predict chemo success after just one dose
Diagnosis Not yet recruiting1. Study Design Overview Study Type: Single-center, prospective, observational, diagnostic study. Primary Objective: To validate whether Super-Resolution Ultrasound Imaging (SRUS) can accurately predict pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in bre…
Sponsor: Anhui Provincial Cancer Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New HIV combo pill tested alongside TB treatment in small trial
Disease control Not yet recruitingThis is a prospective, multicenter, open-label, parallel-controlled study. The primary objective is to prospectively explore and compare the virological efficacy of Ainuovirine/Lamivudine/Tenofovir and Efavirenz/Lamivudine/Tenofovir regimens combined with rifampicin and isoniazid…
Phase: PHASE4 • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New shot aims to reverse liver scarring in MASH patients
Disease control Not yet recruitingThis is a Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-design clinical trial to evaluate efficacy and safety of QL2401 in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis (F2-F3).
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Immune cells take on nerve tumors: new trial launches
Disease control Recruiting nowThe primary objective of this study is to verify the safety of antigen-specific T cells (CAR-T) and engineered immune effector cytotoxic T cells (EIE) modified by immunoregulatory genes and immune modified dendritic cell vaccine (DCvac) in the treatment of neurofibromatosis or sc…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New pill aims to bring back color to vitiligo skin
Disease control Not yet recruitingThe purpose of this clinical trial is to learn how well ACT-777991 works, how safe it is and how well it is tolerated by adults with non-segmental vitiligo. The main question this clinical trial aims to answer is: • Can ACT-777991 help return color to the skin of the face of ad…
Phase: PHASE2 • Sponsor: Idorsia Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Blood-Based injection may offer new hope for chronic back pain without burning nerves
Symptom relief Not yet recruitingThe first clinical research effort under this initiative is a pilot randomized controlled trial comparing intra-periarticular lumbar facet platelet-rich plasma (PRP) injection to standard-of-care medial branch radiofrequency ablation (RFA) for chronic lumbar facet-mediated pain. …
Phase: NA • Sponsor: The New England Baptist Hospital • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC